KOKO Medical Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$8M
- Investors
-
2
KOKO Medical General Information
Description
Developer of a medical device designed to offer rapid postpartum hemorrhage intervention. The company utilizes catheter-based technology that contains a fabric that grasps cells as they navigate through the fallopian tubes during a hysteroscopic procedure and collects cells that can be tested for early cancer indicators, enabling healthcare providers to detect the early stages of ovarian cancer, provide initial treatment, and reduce unnecessary fertility-ending surgeries.
Contact Information
Website
www.kokomed.comCorporate Office
- 770 Pennsylvania Drive
- Suite 100
- Exton, PA 19341
- United States
Corporate Office
- 770 Pennsylvania Drive
- Suite 100
- Exton, PA 19341
- United States
KOKO Medical Timeline
KOKO Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 13-Feb-2026 | $8M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series B) | 15-Dec-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 19-Jan-2023 | $12.5M | $16.4M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 15-Nov-2021 | $3.87M | $3.87M | Completed | Generating Revenue |
KOKO Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 581,886 | $0.000100 | 8% | $3.44 | $3.44 | 1x | $3.44 | 6.16% |
| Series A-1 | 814,387 | $0.000100 | 8% | $7.29 | $7.29 | 1x | $7.29 | 8.62% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
KOKO Medical Patents
KOKO Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025137172-A1 | Medical drains with mesh support porous internal axial drain support | Inactive | 18-Dec-2023 | ||
| EP-4784187-A1 | Surgical drains for fluid removal | Pending | 25-Sep-2023 | ||
| WO-2025072386-A1 | Surgical drains for fluid removal | Inactive | 25-Sep-2023 | ||
| WO-2025054617-A1 | Medical drain with shaped insertion tip | Inactive | 07-Sep-2023 | ||
| US-20240366855-A1 | Rolling surgical drain with angled distal tip | Pending | 01-May-2023 | A61M1/87 |
KOKO Medical Signals
KOKO Medical Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amzak Health | Venture Capital | Minority | ||
| ShangBay Capital | Venture Capital | Minority |
KOKO Medical FAQs
-
When was KOKO Medical founded?
KOKO Medical was founded in 2020.
-
Where is KOKO Medical headquartered?
KOKO Medical is headquartered in Exton, PA.
-
What is the size of KOKO Medical?
KOKO Medical has 6 total employees.
-
What industry is KOKO Medical in?
KOKO Medical’s primary industry is Other Devices and Supplies.
-
Is KOKO Medical a private or public company?
KOKO Medical is a Private company.
-
What is the current valuation of KOKO Medical?
The current valuation of KOKO Medical is .
-
What is KOKO Medical’s current revenue?
The current revenue for KOKO Medical is .
-
How much funding has KOKO Medical raised over time?
KOKO Medical has raised $30.4M.
-
Who are KOKO Medical’s investors?
Amzak Health and ShangBay Capital have invested in KOKO Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process